|Offers assistance in||Contact Information|
Biotech Executive, CEO
Mark Velleca joined G1 Therapeutics as CEO in May 2014. Previously, he was a founder and SVP of CGI Pharmaceuticals, where he guided the company from its inception (as a Yale incubated start-up) through its establishment as a drug discovery company that brought multiple drug candidates into clinical trials. When CGI was acquired by Gilead in 2010, Dr. Velleca served as a senior advisor to Gilead. He helped the company build its oncology pipeline through prioritization of internal programs, academic partnerships, in-licensing, technology deals and acquisitions. He most recently served as EVP at The Leukemia & Lymphoma Society. Earlier in his career, he was an attending physician at Yale New Haven Hospital and on the faculty of Yale Medical School. He earned a B.S. in biology Cum Laude from Yale and an M.D. and Ph.D. in neuroscience from Washington University in St. Louis. He has served on the board of directors of BioMarker Strategies, a Johns Hopkins-founded oncology diagnostics company, as well as the scientific advisory boards of Intellikine (a UCSF-founded drug discovery company that was acquired by Takeda in 2011) and BioRelix, a Yale-founded antibiotics drug discovery company.
Dr. Velleca is happy to explore discussions regarding entrepreneurship,drug discovery and development, biotechnology, precision medicine, genomics, healthcare policy, and health IT.
Liz Wessoleck is former Sr. Administrative Assistant to the Head of College - Morse College. She has served as the same to the Head of College - Calhoun College, and prior to that as the Administrative Assistant to Dean of Branford College.
Ms. Wessoleck pursues travel and is a former ex-pat who continues to be interested in living abroad.
Werner P. Wolf
Raymond Wean Professor Emeritus of Engineering and Applied Science, Professor Emeritus of Physics
Werner Wolf was a Yale professor of Engineering and Applied Science and professor of Physics for 39 years, and retired in 2002. Before that he was at Oxford University for 14 years as an undergraduate, graduate student and as a faculty member. His research field was Condensed Matter Physics (Magnetic materials and low temperatures). Professor Wolf was very active chairman, DUS and DGS for many years and has insight into the differences between Engineering, Applied Physics and Physics. He is also happy to provide insight into the significant differences between studying at Yale and at Oxford.
In the past, Prof. Wolf has discussed applications for Rhodes and Marshall Scholarships with students planning to study in the United Kingdom and would be pleased to do that again. He has also traveled extensively in Europe and many other parts of the world, and is always interested in hearing about travel plans. Closer to home he is interested in chamber music and operas.
Director of Development, Yale College and Special Initiatives
Martha Woodcock has been the Director of Development for Yale College and Special Initiatives since March 2012. She came to Yale in 2002 as a major gift officer in the Yale Development Office. Later she became a Deputy Director of Major Gifts in 2007, and then served as Senior Associate Director in Principal Gifts from 2010-2012. Prior to Yale,Ms. Woodcock was a consultant in the executive search industry, and served in development roles at the University of Pennsylvania and Drexel University. A Pennsylvania native, she received her BA in History from the University of Pennsylvania in 1995. She lives in North Haven with her husband Edward SOM ‘04, and daughter Catherine (age 2 ½).
Ms. Woodcock has interests in philanthropy, instrumental music (clarinet, saxophone, baritone horn,) vocal music (alto,) theater arts, photography and American history.